Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
The Ragnarok Mortar Mission Module has demonstrated its ability to quickly switch platforms, presenting scope for it to be employed for multiple requirements. On the show floor at DSEI 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results